Abstract:The rates of RNA synthesis in cultured human KB cells infected by adenovirus 2 were estimated by measuring the endogenous RNA polymerase activities in isolated nuclei. The fungal toxin α-amanitin was used to determine the relative and absolute levels of RNA synthesis by RNA polymerases I, II, and III in nuclei isolated during the course of infection. Whereas the level of endogenous RNA polymerase I activity in nuclei from infected cells remained constant relative to the level in nuclei from mock-infected cells, the endogenous RNA polymerase II and III activities each increased about 10-fold. These increases in endogenous RNA polymerase activities were accompanied by concomitant increases in the rates of synthesis in isolated nuclei of viral mRNA precursor, which was monitored by hybridization to viral DNA, and of viral 5.5S RNA, which was quantitated by electrophoretic analysis on polyacrylamide gels. The cellular RNA polymerase levels were measured with exogenous templates after solubilization and chromatographic resolution of the enzymes on DEAE-Sephadex, using procedures in which no losses of activity were apparent. In contrast to the endogenous RNA polymerase activities in isolated nuclei, the cellular levels of the solubilized class I, II, and III RNA polymerases remained constant throughout the course of the infection. Furthermore, no differences were detected in the chromatographic properties of the RNA polymerases obtained from infected or control mock-infected cells. These observations suggest that the increases in endogenous RNA polymerase activities in isolated nuclei are not due to variations in the cellular concentrations of the enzymes. Instead, it is likely that the increased endogenous enzyme activities result from either the large amounts of viral DNA template available as a consequence of viral replication or from functional modifications of the RNA polymerases or from a combination of these effects.

Parvovirus B19 and immune disorders

Model Following Control of a Unicycle Mobile Robot via Dynamic Feedback Linearization Based on Piecewise Bilinear Models

DEAD on

High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic disease

Parvovirus B19 in Rheumatic Diseases

Does parvovirus infection have a role in systemic lupus erythematosus?

Bevacizumab in Combination with Taxane versus Non-Taxane Containing Regimens for Advanced/Metastatic Nonsquamous Non–Small-Cell Lung Cancer: A Systematic Review

[Review of correlation between human parvovirus B19 and autoimmune disease etiology]

Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway?

The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease

Molecular characterization of two bipartite geminiviruses causing squash leaf curl disease: role of viral replication and movement functions in determining host range.

Best Practice Guidelines for Forensic Neuropsychological Examinations of Patients With Traumatic Brain Injury

Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis

Rheumatic manifestations and sequela of acute parvovirus B19 infection in hospitalized adult population

Parvovirus B19 induced lupus-like syndrome with nephritis

Over-shift decrease in lung function in poultry slaughterhouse workers.

Viral RNA Synthesis and Levels of DNA-Dependent RNA Polymerases During Replication of Adenovirus 2

[Correlations Between Viral Serology and Different Clinical Characteristics in Patients with Lupus Nephropathy].

Erythema nodosum manifestation of Parvovirus B19-associated reactive arthritis

Pericarditis and pleuritis associated with human parvovirus B19 infection in a systemic lupus erythematosus patient

A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infection